T&L Co. Ltd Cash Flow Conversion Efficiency
T&L Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, T&L Co. Ltd (340570) has a cash flow conversion efficiency ratio of 0.096x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩21.46 Billion ≈ $14.54 Million USD) by net assets (₩224.21 Billion ≈ $151.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of T&L Co. Ltd (2018–2025)
Cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2025. This chart illustrates how T&L Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View T&L Co. Ltd (340570) stock price for real-time trading data and today's change.
T&L Co. Ltd Cash Flow Conversion Ratio Explained
T&L Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
T&L Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of T&L Co. Ltd ranked by their cash flow conversion efficiency. Also see 340570 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Zhengyuan Zhihui Technology Co Ltd
SHE:300645
|
0.056x |
|
MM Forgings Limited
NSE:MMFL
|
0.196x |
|
AudioCodes Ltd
TA:AUDC
|
0.023x |
|
Tianjin Meiteng Technology Co. Ltd. A
SHG:688420
|
N/A |
|
EnviTec Biogas AG
XETRA:ETG
|
0.086x |
|
NEXCOM International Co Ltd
TWO:8234
|
0.017x |
|
Vogenx Inc Common Stock
NASDAQ:VOGX
|
-0.015x |
|
CERRO DE PASCO RES
F:N8HP
|
-0.043x |
Annual Cash Flow Conversion Efficiency for T&L Co. Ltd (2018–2025)
The table below shows the annual cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2025. Review T&L Co. Ltd (340570) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩201.16 Billion ≈ $136.32 Million |
₩37.69 Billion ≈ $25.54 Million |
0.187x | -31.02% |
| 2024-12-31 | ₩171.44 Billion ≈ $116.18 Million |
₩46.57 Billion ≈ $31.56 Million |
0.272x | +7.98% |
| 2023-12-31 | ₩129.55 Billion ≈ $87.80 Million |
₩32.59 Billion ≈ $22.09 Million |
0.252x | +73.19% |
| 2022-12-31 | ₩106.07 Billion ≈ $71.88 Million |
₩15.41 Billion ≈ $10.44 Million |
0.145x | -31.15% |
| 2021-12-31 | ₩90.09 Billion ≈ $61.05 Million |
₩19.01 Billion ≈ $12.88 Million |
0.211x | +62.45% |
| 2020-12-31 | ₩71.95 Billion ≈ $48.76 Million |
₩9.34 Billion ≈ $6.33 Million |
0.130x | -44.91% |
| 2019-12-31 | ₩33.23 Billion ≈ $22.52 Million |
₩7.83 Billion ≈ $5.31 Million |
0.236x | +0.50% |
| 2018-12-31 | ₩27.24 Billion ≈ $18.46 Million |
₩6.39 Billion ≈ $4.33 Million |
0.235x | -- |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more